Skip to content

Safety evaluation of long term intake of test supplement

Safety evaluation of long term intake of test supplement - Safety evaluation of long term intake of test supplement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044208
Enrollment
60
Registered
2021-05-16
Start date
2021-05-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male and female whose age is between 20 and 64 years old.

Exclusion criteria

Exclusion criteria: 1. Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function. 2. Subjects who have allergy related to this study. 3. Subjects who have diseases requiring continuous medication, or serious medical history who needed medication. 4. Subjects whose clinical laboratory tests, blood pressure, and physical measurements before intake of trial supplements are significantly out of the standard values. 5. Subjects who have participated in other clinical studies. 6. Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 7. Subjects who are judged as unsuitable for the study based on the answers of background survey. 8. Subjects who are judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Body weight/body mass index Doctor's question Adverse event

Countries

Japan

Contacts

Public ContactSaki Miyayama

EP Mediate Co., Ltd. Development Business Headquarters, TTC Center, Trial Planning Department

miyayama392@eps.co.jp03-5657-4983

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026